People · Operator
Named in public records as an officer, director or promoter · active 2015–2017 · Other Technology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ellipse Technologies Inc | — | Other Technology | Series B | $75.4M | $304.6M | 2015 |
| Rebound Therapeutics Corp | — | Pharma | Series B | $20.3M | $561.1M | 2015 |
Tracy R. Pearson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tracy R. Pearson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael R. Henson | 2 | 9 |
| Jeffrey J. Valko | 1 | 4 |
| Thomas R. Thaler | 1 | 3 |
| Samuel R. Shaolian | 1 | 3 |
| Paul R. Mieyal | 1 | 3 |
| John R. Kilcoyne | 1 | 2 |
| Nicholas R. Lembo, MD | 1 | 1 |
| Blair R. Walker | 1 | 1 |
| Nicholas R. Lembo | 1 | 1 |
| J. Todd Koning | 1 | 1 |
| Ed R. Roschak | 1 | 1 |
| Mike Todd Moeller | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.